A breakthrough in Alzheimer's research has identified a single protein that could significantly change the disease's trajectory. Scientists have pinpointed how a gene mutation enhances the protein reelin, which is crucial for brain cell function.
This mutation effectively boosts reelin's ability to combat toxic amyloid plaques and tau tangles, the hallmarks of Alzheimer's. The discovery stems from studying a unique population in Colombia with a high prevalence of an aggressive Alzheimer's-causing gene mutation, PSEN1.
Researchers found that a protective mutation, dubbed COLBOS, strengthens reelin's binding to other molecules, concentrating its beneficial effects on brain cell surfaces. This enhanced reelin signaling appears to slow key Alzheimer's processes, such as tau protein phosphorylation, thereby delaying cognitive decline.
While the COLBOS mutation may delay, not entirely prevent, the disease in those with the PSEN1 mutation, the findings offer a promising foundation for future therapies. Scientists are exploring gene therapy approaches to enhance reelin signaling, which could potentially delay Alzheimer's by decades, a significant improvement over current treatments.